Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein L32 pseudogene 26 (RPL32P26)
- Target
- RPL32P26
- Molecular classification
- Other (pseudogene)
01
Overview
Ribosomal protein L32 pseudogene 26 (RPL32P26) is a human pseudogene, meaning it is a DNA sequence similar to a functional gene (ribosomal protein L32, RPL32) but is non-functional and does not code for a protein. Pseudogenes such as RPL32P26 are genomic residues of once-functional genes, generated through gene duplication or retrotransposition. While the parental gene RPL32 encodes a component of the ribosomal 60S subunit, RPL32P26 itself is not translated or involved in ribosome structure or function. Unlike functional ribosomal proteins, RPL32P26 does not participate in cellular processes or diseases and has no known drug interactions or biological effects. It serves mainly as a genomic marker and can be useful in comparative genomics but is not considered a therapeutic target or biomarker.
- Other names
- RPL32_17_1245RPL32P26
02
Mechanism of action
Not applicable (does not encode a protein product)
03
Biological functions
None; as a pseudogene, RPL32P26 does not encode a functional protein and typically lacks biological activity
04
Disease associations
None known; no published association with diseases or direct biological role
05
Safety considerations
None reported; as a non-coding pseudogene, RPL32P26 does not possess known safety or toxicity issues
06
Biomarkers
None reported for RPL32P26; however, other ribosomal protein genes (not pseudogenes) have been explored as biomarkers in various contexts
Beyond the preview
Go deeper on Ribosomal protein L32 pseudogene 26 (RPL32P26).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Ribosomal protein L32 pseudogene 26 (RPL32P26).